NEXT Oncology - Virginia Cancer Specialists is a clinical research site located in Fairfax, Virginia, United States 22031.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
NEXT Oncology - Virginia Cancer Specialists has participated in 5 clinical trials with 4 currently active.
Therapeutic areas: HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer.
Sponsors: Iambic Therapeutics, Inc, Whitehawk Therapeutics, Inc., Nuvalent Inc..
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
NEXT Oncology - Virginia Cancer Specialists has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NEXT Oncology - Virginia Cancer Specialists has 5 clinical trials on record, with 4 currently active. Their work covers HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer.
Yes — NEXT Oncology - Virginia Cancer Specialists holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.